Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland Health Focus.
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
GlobeNewswire, Inc.
·
July 1, 2025
REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited...
European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)
GlobeNewswire, Inc.
·
June 23, 2025
REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered...
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
GlobeNewswire, Inc.
·
June 6, 2025
REYKJAVIK, Iceland, June 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
GlobeNewswire, Inc.
·
June 2, 2025
REYKJAVIK, Iceland, June 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
GlobeNewswire, Inc.
·
June 25, 2025
REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv...
Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility
GlobeNewswire, Inc.
·
June 26, 2025
REYKJAVIK, Iceland, June 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its lenders...
Main Results of 2025 Annual and Extraordinary General Meeting
GlobeNewswire, Inc.
·
June 25, 2025
REYKJAVÍK, Iceland and LUXEMBOURG, June 25, 2025 (GLOBE NEWSWIRE) -- The 2025 Annual and Extraordinary General Meeting (the "2025 AGM") of Alvotech (the "Company") was held on June 25, 2025, at Arendt House, 41A Avenue John F. Kennedy, L-2082...
Triple-Track Investment Portfolio: LifeScience Compliance Platform, TV series, and Cat-Human Vocalization
EIN Presswire
·
June 26, 2025
FGC 2.3 Feline Vocalization, Skyward Dragons, and a New Global Regulatory-Affairs SaaS Marketplace NEW YORK CITY, FL, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- Visionary physician-scientist and entrepreneur Dr. Vlad Reznikov, MD, PhD,...
argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy
GlobeNewswire, Inc.
·
June 20, 2025
VYVGART® SC, first-and-only IgG Fc-antibody fragment which specifically targets the neonatal Fc receptor (FcRn), now approved for use in Europe for CIDP Approval based on ADHERE clinical trial, the largest study of CIDP patients to date First...
Arctic Exceptionalism as Myth, Method, and Mirror
The Arctic Institute
·
June 24, 2025
Back to Publications Meteor shower and Northern Lights over Snæfellsnes glacier, Iceland. Photo: Diana Robinson There is a story we tell ourselves about the Arctic. Every Arctic expert knows it by heart. It began in Murmansk, 1987, when Soviet...
Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy
GlobeNewswire, Inc.
·
June 18, 2025
SAN DIEGO, June 18, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) recently participated in the European Society of Human Genetics (ESHG) conference held in Milan, Italy, from May 24-27, 2025. The event highlighted the use of optical...
The Arctic This Week Take Five: Week of 9 June, 2025
The Arctic Institute
·
June 13, 2025
Back to Publications Quebec Authorities Monitoring Tuberculosis Outbreaks in Nunavik As reported by CBC News on June 10, Quebec’s public health service stated that it is closely monitoring the increasing number of tuberculosis cases in Nunavik....
Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors
GlobeNewswire, Inc.
·
June 11, 2025
Alvotech (NASDAQ: ALVO, ALVO-SDB, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completion of a private placement that was carried out...
Seaweed Market Worth Observing Growth Rate of 9.5% from 2025 to 2034 | Annie Chun's, Inc., Brandt, Inc., Cargill
EIN Presswire
·
June 17, 2025
WILMINGTON, DE, UNITED STATES, June 17, 2025 /EINPresswire.com/ -- The seaweed market size was valued at $7.5 billion in 2024, and is estimated to reach $18.1 billion by 2034, growing at a CAGR of 9.5% from 2025 to 2034. Seaweed is a diverse...
European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
GlobeNewswire, Inc.
·
June 6, 2025
Now approved in the EU, Duvyzat offers an important treatment option for delaying Duchenne muscular dystrophy (DMD) disease progression Duvyzat is an orally administered treatment for DMD in patients 6 years and older who are able to walk The...
Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)
GlobeNewswire, Inc.
·
June 5, 2025
HYDERABAD, India and REYKJAVIK, Iceland, June 05, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr....
United Kingdom Falls to 12th Spot in 2025 World Citizenship Index, as Switzerland Claims Top Rank
EIN Presswire
·
June 23, 2025
LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- The United Kingdom has secured the 12th position in the 2025 World Citizenship Index (WCI), released by CS Global Partners in their much-anticipated annual World Citizenship Report....
Oculis to Participate in Upcoming June Investor Conferences
GlobeNewswire, Inc.
·
June 3, 2025
ZUG, Switzerland, June 03, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet...
Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million
GlobeNewswire, Inc.
·
June 5, 2025
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, RUSSIA,...
Oculis Publishes Results of 2025 Annual General Meeting
GlobeNewswire, Inc.
·
June 5, 2025
ZUG, Switzerland, June 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), today announced the results from its 2025 Annual General Meeting held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11,...